BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18289100)

  • 1. Importance of iron and iron metabolism in nonalcoholic fatty liver disease.
    Baptista-Gonzalez H; Chavez-Tapia NC; Zamora-Valdés D; Uribe M; Mendez-Sanchez N
    Mini Rev Med Chem; 2008 Feb; 8(2):171-4. PubMed ID: 18289100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-alcoholic steatohepatitis with iron: part of insulin resistance-associated hepatic iron overload?
    Moirand R; Mendler MH; Guillygomarc'h A; Brissot P; Deugnier Y
    J Hepatol; 2000 Dec; 33(6):1024-6. PubMed ID: 11131442
    [No Abstract]   [Full Text] [Related]  

  • 3. Iron overload in nonalcoholic steatohepatitis.
    Fujita N; Takei Y
    Adv Clin Chem; 2011; 55():105-32. PubMed ID: 22126026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions between hepatic iron and lipid metabolism with possible relevance to steatohepatitis.
    Ahmed U; Latham PS; Oates PS
    World J Gastroenterol; 2012 Sep; 18(34):4651-8. PubMed ID: 23002334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of iron, insulin resistance, and nonalcoholic steatohepatitis.
    Chitturi S; George J
    Curr Gastroenterol Rep; 2003 Feb; 5(1):18-25. PubMed ID: 12530944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mice lacking liver-specific β-catenin develop steatohepatitis and fibrosis after iron overload.
    Preziosi ME; Singh S; Valore EV; Jung G; Popovic B; Poddar M; Nagarajan S; Ganz T; Monga SP
    J Hepatol; 2017 Aug; 67(2):360-369. PubMed ID: 28341391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron as a co-morbid factor in nonhemochromatotic liver disease.
    Bonkovsky HL; Lambrecht RW; Shan Y
    Alcohol; 2003 Jun; 30(2):137-44. PubMed ID: 12957298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Involvement and role of iron in nonalcoholic steatohepatitis].
    Cojocariu C; Trifan A; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(2):308-12. PubMed ID: 19294996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron and steatohepatitis.
    Corradini E; Pietrangelo A
    J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2():42-6. PubMed ID: 22320915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron overload is associated with hepatic oxidative damage to DNA in nonalcoholic steatohepatitis.
    Fujita N; Miyachi H; Tanaka H; Takeo M; Nakagawa N; Kobayashi Y; Iwasa M; Watanabe S; Takei Y
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):424-32. PubMed ID: 19190144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis.
    Fargion S; Mattioli M; Fracanzani AL; Sampietro M; Tavazzi D; Fociani P; Taioli E; Valenti L; Fiorelli G
    Am J Gastroenterol; 2001 Aug; 96(8):2448-55. PubMed ID: 11513189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paying the Iron Price: Liver Iron Homeostasis and Metabolic Disease.
    Ameka M; Hasty AH
    Compr Physiol; 2022 Jun; 12(3):3641-3663. PubMed ID: 35766833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Alcoholic and nonalcoholic steatohepatitis: the same disease! I. Diagnosis and mechanisms].
    Spahr L; Rubbia-Brandt L; Hadengue A
    Rev Med Suisse; 2005 Sep; 1(31):2026-8, 2030-1. PubMed ID: 16212004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Non-alcoholic fatty liver disease].
    Calderaro J; Zafrani ES
    Ann Pathol; 2010 Dec; 30(6):413-20. PubMed ID: 21167426
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of iron overload in a rat nutritional model of non-alcoholic fatty liver disease.
    Kirsch R; Sijtsema HP; Tlali M; Marais AD; Hall Pde L
    Liver Int; 2006 Dec; 26(10):1258-67. PubMed ID: 17105592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron overload causes oxidative stress and impaired insulin signaling in AML-12 hepatocytes.
    Messner DJ; Rhieu BH; Kowdley KV
    Dig Dis Sci; 2013 Jul; 58(7):1899-908. PubMed ID: 23558563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high-fat diet modulates iron metabolism but does not promote liver fibrosis in hemochromatotic Hjv⁻/⁻ mice.
    Padda RS; Gkouvatsos K; Guido M; Mui J; Vali H; Pantopoulos K
    Am J Physiol Gastrointest Liver Physiol; 2015 Feb; 308(4):G251-61. PubMed ID: 25501544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic steatohepatitis and noncirrhotic hepatocellular carcinoma: fertile soil.
    Torres DM; Harrison SA
    Semin Liver Dis; 2012 Feb; 32(1):30-8. PubMed ID: 22418886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of evidence for the pathogenic role of iron and HFE gene mutations in Brazilian patients with nonalcoholic steatohepatitis.
    Deguti MM; Sipahi AM; Gayotto LC; Palácios SA; Bittencourt PL; Goldberg AC; Laudanna AA; Carrilho FJ; Cançado EL
    Braz J Med Biol Res; 2003 Jun; 36(6):739-45. PubMed ID: 12792703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical evaluation of the role of iron overload in fatty liver disease.
    Fernandez M; Lokan J; Leung C; Grigg A
    J Gastroenterol Hepatol; 2022 Oct; 37(10):1873-1883. PubMed ID: 35906772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.